EGRP News Flash - January 9, 2013
New NIH Common Fund Request for Applications for Functional Epigenomics
The National Institutes of Health (NIH) recently announced a new Common Fund Request for Applications (RFAs) in the NIH Guide for Grants and Contracts, RFA-RM-12-026, inviting proposals to stimulate innovative research to develop novel tools and technologies that enable at least one of the following: tissue or cell-specific manipulation of epigenetic modifications or their effector molecules, temporal manipulation of the epigenome, locus-specific manipulation of the epigenome, or novel approaches that enable any combination of these three things. All Common Fund initiatives invite investigators to develop bold, innovative, and often risky approaches to address problems that may seem intractable or to seize new opportunities that offer the potential for rapid progress.
The total amount of funds available for these awards is approximately $3.8 million per year for Fiscal Year (FY) 2013 through FY2017, contingent upon the receipt of scientifically meritorious applications. Six to nine awards are anticipated from this solicitation. Application budgets may not exceed $325,000 in direct costs and must reflect the actual needs of the proposed project. The project period may not exceed five years.
Letters of intent are due February 27, 2013. The application due date is March 27, 2013.
Learn more about the Common Fund's Epigenomics Project.
View more information about the Epidemiology and Genomics Research Program's (EGRP) interests in cancer epigenomics.
For cancer epidemiology questions, contact Mukesh Verma, Ph.D., Chief, Methods and Technologies Branch, EGRP, Division of Cancer Control and Population Sciences (DCCPS), National Cancer Institute (NCI).
Access the NIH Guide for Grants and Contracts for details:
- RFA-RM-12-026 (R01)